https://investors.modernatx.com/events-presentations 1.0 monthly 2026-02-19 https://investors.modernatx.com/investor-contacts 1.0 monthly 2026-01-13 https://investors.modernatx.com/investor-faqs 1.0 monthly 2026-02-13 https://investors.modernatx.com/annual-reports 1.0 monthly 2026-03-16 https://investors.modernatx.com/sec-filings 1.0 monthly 2026-01-13 https://investors.modernatx.com/committee-composition 1.0 monthly 2026-01-13 https://investors.modernatx.com/leadership-team 1.0 monthly 2026-03-02 https://investors.modernatx.com/development-programs 1.0 monthly 2026-01-13 https://investors.modernatx.com/analyst-coverage 1.0 monthly 2026-01-13 https://investors.modernatx.com 1.0 monthly 2026-02-24 https://investors.modernatx.com/information-request-form 1.0 monthly 2026-01-13 https://investors.modernatx.com/stock-info 1.0 monthly 2026-01-13 https://investors.modernatx.com/scientific-medical-meetings 1.0 monthly 2026-02-06 https://investors.modernatx.com/statements-perspectives 1.0 monthly 2026-01-13 https://investors.modernatx.com/governance-documents 1.0 monthly 2026-01-13 https://investors.modernatx.com/quarterly-results 1.0 monthly 2026-01-13 https://investors.modernatx.com/investor-days 1.0 monthly 2026-01-13 https://investors.modernatx.com/investor-email-alerts 1.0 monthly 2026-01-13 https://investors.modernatx.com/statement-on-the-safety-of-spikevax 0.8 monthly 2026-01-13 https://investors.modernatx.com/moderna-recognizes-the-success-of-operation-warp-speed-and-its-ongoing-commitment-to-transparency 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2025/ir-insights-recapping-our-second-quarter-of-2025-earnings-report 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2025/a-difficult-but-necessary-step-forward 0.8 monthly 2026-01-13 https://investors.modernatx.com/statements-perspectives/moderna-announces-an-organizational-restructuring 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2023/leveraging-13-years-of-investment-in-mrna-innovation-for-future-pandemic-preparedness 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2023/university-of-minnesota-commencement-remarks-to-the-class-of-2023 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2025/ir-insights-recapping-our-first-quarter-of-2025-earnings-report 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2013/moderna-therapeutics-appoints-theo-melas-kyriazi-to-board-of-directors 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2013/moderna-closes-new-financing-round-raising-110m-to-develop-messenger-rna-therapeutics 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2013/moderna-therapeutics-named-to-the-world-economic-forums-community-of-global-growth-companies 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2013/moderna-therapeutics-announces-expansion-to-new-headquarters-and-laboratories-at-200-tech-square 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2013/darpa-awards-moderna-therapeutics-a-grant-for-up-to-25-million-to-develop-messenger-rna-therapeutics 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2013/moderna-therapeutics-named-a-fierce-15-biotech-company-for-2013 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2013/study-published-in-nature-biotechnology-demonstrates-ability-of-modernas-novel-therapeutic-paradigm-to-repair-and-regenerate-damaged-heart-tissue 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2013/biotech-industry-veteran-joseph-bolen-joins-moderna-therapeutics-to-be-president-of-research-and-development 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2013/industry-leader-john-reynders-joins-moderna-therapeutics-as-chief-information-officer 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2013/henri-a-termeer-joins-moderna-therapeutics-board-of-directors 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2013/astrazeneca-and-moderna-therapeutics-announce-exclusive-agreement-to-develop-pioneering-messenger-rna-therapeutics-in-cardiometabolic-diseases-and-cancer 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2013/moderna-appoints-divakar-ramamakishnan-phd-as-senior-vice-president-of-process-development-manufacturing-and-quality 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2014/moderna-therapeutics-to-present-at-32nd-annual-jp-morgan-healthcare-conference 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2014/alexion-pharmaceuticals-and-moderna-therapeutics-announce-exclusive-strategic-agreement-to-develop-messenger-rna-therapeutics-for-rare-diseases 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2014/moderna-launches-onkaido-therapeutics-to-focus-on-the-development-of-mrna-therapeutics-in-oncology-with-20-million-capital-commitment 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2014/moderna-appoints-biotechnology-investment-banking-veteran-lorence-kim-as-chief-financial-officer 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2014/moderna-forms-technology-advisory-board-to-provide-expertise-for-the-companys-gmp-manufacturing-strategy 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2014/moderna-announces-expansion-to-new-facility-in-kendall-square 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2014/moderna-named-to-cnbc-disruptor-50-list 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2014/moderna-appoints-oncology-leader-dr-stephen-kelsey-as-president-of-onkaido 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2014/moderna-to-collaborate-with-karolinska-institutet-and-karolinska-university-hospital-on-discovery-of-new-messenger-rna-therapeutics 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2015/moderna-launches-caperna-llc-its-fourth-venture-to-develop-personalized-cancer-vaccines 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2015/moderna-launches-third-venture-company-elpidera-for-rare-diseases 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2015/moderna-1-on-cnbc-disruptor-50-list 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2015/moderna-appoints-tal-zaks-former-head-of-sanofi-global-oncology-as-chief-medical-officer 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2015/moderna-and-institut-pasteur-sign-strategic-research-collaboration 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2015/moderna-announces-license-and-collaboration-agreement-with-merck-to-develop-messenger-rna-based-antiviral-vaccines-and-passive-immunity-therapies 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2015/moderna-launches-new-venture-valera-llc-for-infectious-diseases 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2015/onkaido-announces-appointment-of-michael-j-morin-phd-as-chief-scientific-officer 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2015/moderna-to-present-at-33rd-annual-jp-morgan-healthcare-conference 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2015/moderna-closes-450-million-financing-to-support-growth-of-messenger-rna-therapeutics-platform-across-diverse-therapeutic-areas 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2015/dr-elizabeth-nabel-joins-moderna-therapeutics-board-of-directors 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2016/moderna-therapeutics-named-the-no-3-top-employer-by-science-magazine 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2016/moderna-appoints-annie-seibold-drapeau-as-chief-human-resources-officer 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2016/moderna-to-build-state-of-the-art-fully-integrated-gmp-mrna-clinical-manufacturing-facility-in-norwood-mass 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2016/moderna-appoints-melissa-j-moore-phd-as-chief-scientific-officer-of-modernas-mrna-research-platform 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2016/moderna-announces-funding-award-from-barda-for-8-million-with-potential-of-up-to-125-million-to-accelerate-development-of-zika-messenger-rna-mrna-vaccine 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2016/moderna-enters-new-growth-phase-with-closing-of-474-million-equity-financing-and-its-first-barda-grant-for-up-to-125-million-for-zika-mrna-vaccine 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2016/moderna-therapeutics-provides-mid-year-corporate-update-announces-continued-clinical-development-progress-and-pipeline-acceleration 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2016/astrazeneca-and-moderna-announce-filing-of-first-clinical-trial-application-in-messenger-rna-therapeutics-collaboration 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2016/vertex-and-moderna-establish-exclusive-collaboration-to-discover-and-develop-mrna-therapeutics-for-cystic-fibrosis 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2016/merck-and-moderna-announce-strategic-collaboration-to-advance-novel-mrna-based-personalized-cancer-vaccines-with-keytruda-pembrolizumab-for-the-treatment-of-multiple-types-of-cancer 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2016/moderna-therapeutics-and-charles-river-laboratories-announce-strategic-collaboration-to-scale-modernas-nonclinical-development-efforts-for-novel-mrna-therapeutics 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2016/moderna-announces-appointment-of-dr-michael-watson-as-president-of-valera 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2016/moderna-therapeutics-appoints-saqib-islam-as-chief-business-officer 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2016/moderna-therapeutics-through-valera-its-infectious-disease-venture-announces-initial-grant-of-up-to-20-million-to-advance-mrna-based-antibody-combination-to-help-prevent-hiv-infection 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2016/moderna-licenses-new-vaccine-candidates-against-a-new-viral-target-to-merck 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2016/moderna-therapeutics-announces-transition-to-a-clinical-stage-company-provides-business-update-and-outlines-2016-strategic-priorities 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2016/astrazeneca-and-moderna-therapeutics-announce-new-collaboration-to-co-develop-and-co-commercialize-immuno-oncology-mrna-therapeutics 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2016/moderna-therapeutics-to-present-at-2016-jp-morgan-healthcare-conference 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2012/moderna-announces-40-million-in-financing-to-advance-development-of-new-biotherapeutic-modality-messenger-rna-therapeutics 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2012/moderna-appoints-stephen-hoge-as-senior-vice-president-of-corporate-development-and-new-drug-concepts 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2017/moderna-publishes-preclinical-data-in-cell-reports-on-mrna-therapeutic-to-treat-rare-liver-disease-methylmalonic-acidemia-mma-a-disorder-of-organic-acid-metabolism 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2017/moderna-announces-first-in-human-dosing-for-phase-1-study-keynote-603-of-mrna-4157-a-personalized-cancer-vaccine-for-the-treatment-of-solid-tumors 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2017/moderna-announces-new-collaboration-with-astrazeneca-to-co-develop-and-co-commercialize-relaxin-mrna-therapeutic-for-heart-failure 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2017/moderna-named-one-of-global-biopharmaceutical-industrys-top-employers-in-science-magazines-annual-survey 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2017/stephen-berenson-joins-modernas-board-of-directors 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2017/moderna-announces-publication-in-molecular-therapy-characterizing-potent-immune-response-generated-by-its-mrna-prophylactic-vaccines 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2017/moderna-announces-pipeline-and-corporate-update 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2017/industry-veteran-juan-andres-joins-moderna-as-senior-vice-president-of-late-stage-technical-development-and-manufacturing 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2017/moncef-m-slaoui-phd-joins-modernas-board-of-directors 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2017/moderna-provides-update-on-mrna-rare-disease-research-and-development-strategy 0.8 monthly 2026-01-13 https://investors.modernatx.com/news-details/2017/publication-in-cell-demonstrates-modernas-zika-mrna-vaccine-prevents-in-utero-transmission-of-zika-virus-in-mice-protects-against-zika-related-congenital-damage 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2017/melissa-j-moore-phd-chief-scientific-officer-mrna-research-platform-at-moderna-elected-to-national-academy-of-sciences 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2017/moderna-announces-positive-interim-phase-1-clinical-data-demonstrating-first-mrna-vaccine-candidate-mrna-1440-induces-high-levels-of-immunogenicity 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2017/moderna-appoints-israel-ruiz-to-its-board-of-directors 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2017/moderna-provides-pipeline-and-full-year-corporate-update 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2017/moderna-joins-the-human-vaccines-project-to-help-advance-fundamental-understanding-of-the-immune-system 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2017/moderna-to-highlight-its-mrna-development-candidate-pipeline-at-2017-jp-morgan-healthcare-conference 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2018/newly-published-data-in-nature-medicine-show-potential-of-mrna-to-produce-therapeutic-and-protective-protein-levels-in-pre-clinical-models-of-acute-intermittent-porphyria 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2018/dr-wellington-sun-joins-moderna-as-head-vaccine-strategy-and-regulatory-affairs 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2018/moderna-named-a-top-employer-by-science-for-the-fourth-consecutive-year 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2018/moderna-opens-new-manufacturing-site-in-norwood-ma 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2018/moderna-provides-mid-year-corporate-update 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2018/former-akamai-ceo-paul-sagan-joins-modernas-board-of-directors 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2018/moderna-and-merck-expand-mrna-cancer-vaccines-collaboration 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2018/lori-henderson-joins-moderna-as-general-counsel-and-corporate-secretary 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2018/megan-pace-joins-moderna-as-chief-corporate-affairs-officer 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2018/newly-published-data-highlight-modernas-mrna-platform-in-advancing-prophylactic-vaccine-for-cytomegalovirus-cmv-infections 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2018/moderna-closes-500-million-equity-financing 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2018/moderna-announces-an-array-of-clinical-advances-and-outlines-2018-priorities-19-development-candidates-including-10-clinical-programs-highlight-productivity-of-mrna-platform 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2018/dr-john-mendlein-joins-moderna-as-president-corporate-and-product-strategy 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2018/moderna-to-provide-corporate-and-pipeline-updates-and-outline-strategic-priorities-at-2018-jp-morgan-healthcare-conference 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2023/exploring-one-medicine-for-one-patient-individualized-neoantigen-therapies 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2023/impacting-human-health-reflecting-on-our-esg-progress--by-shannon-thyme-klinger-chief-legal-officer 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2023/taking-action-and-raising-awareness-the-impact-of-cytomegalovirus-cmv 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2023/building-the-next-generation-of-moderna-meet-our-spring-co-ops-by-tracey-franklin-chief-human-resources-officer 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2023/3-things-to-know-about-the-2023-2024-covid-19-season-2023-6urzd8ticb 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2023/our-continued-innovation-at-work-celebrating-us-fda-approval-of-our-updated-covid-19-vaccine-2023-cf0vofwvgv 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2023/rd-day-reflections-with-cfo-jamey-mock-2023-xvg5xydrwy 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2023/how-moderna-is-helping-advance-the-fight-against-cancer-2023-skjkrylcd5 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2024/moderna--the-hidden-cost-of-covid-long-covids-impact-on-the-workforce 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2024/ir-insights-recapping-our-third-quarter-2024-earnings-report 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2024/celebrating-us-fda-approval-of-our-updated-covid-19-vaccine-2024-y_tmxvc_vh 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2024/covid-19-summer-surge-three-things-to-know-2024-8dsdhezv_x 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2024/ir-insights-recapping-our-second-quarter-2024-earnings-report-2024-yvv9jsapwj 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2024/understanding-long-covids-impact-on-the-workforce-2024-qh1yyafqgk 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2024/impacting-human-health-reflecting-on-modernas-third-annual-esg-report-2024-sugxfuh4jb 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2024/marking-cmv-awareness-month-in-june-2024-mz9z0i4b00 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2024/the-potential-impact-of-combination-vaccines-on-public-health-2024-tzrnrpno2_ 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2024/ir-insights-recapping-our-fifth-annual-vaccines-day-2024-kb2vznczvr 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2024/long-covid-awareness-day-amplifying-the-patient-voice-2024-hklq5r_sns 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2024/respiratory-syncytial-virus-rsv-what-you-need-to-know-2024-hwvgsfuqsf 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2024/moderna-2023-shareholder-letter 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2025/ir-insights-recapping-our-fourth-quarter-and-fiscal-year-2024-earnings-report 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/news-details/2025/moderna--2024-shareholder-letter-from-ceo-stphane-bancel 0.8 monthly 2026-01-13 https://investors.modernatx.com/news/ir-insights-recapping-business-and-pipeline-updates-from-the-43rd-annual-j-p-morgan-healthcare-conference 0.8 monthly 2026-01-13 https://investors.modernatx.com/statements-perspectives/modernas-statement-on-phase-3-study-of-covid-19-vaccine-protocol-update 0.8 monthly 2026-01-13 https://investors.modernatx.com/statements-perspectives/statement-on-moderna-plan-for-worker-vaccination 0.8 monthly 2026-01-13 https://investors.modernatx.com/statements-perspectives/modernas-commitment-to-vaccines-and-therapeutics-access 0.8 monthly 2026-01-13 https://investors.modernatx.com/statements-perspectives/statement-on-variants-of-the-sars-cov-2-virus 0.8 monthly 2026-01-13 https://investors.modernatx.com/statements-perspectives/statement-on-cyberattack-on-the-european-medicines-agency 0.8 monthly 2026-01-13 https://investors.modernatx.com/statements-perspectives/statement-by-moderna-on-intellectual-property-matters-during-the-covid-19-pandemic 0.8 monthly 2026-01-13 https://investors.modernatx.com/statements-perspectives/statement-from-moderna-on-patent-trial-and-appeal-board-ptab-ruling 0.8 monthly 2026-01-13 https://investors.modernatx.com/statements-perspectives/our-global-commitment-to-vaccine-access 0.8 monthly 2026-01-13 https://investors.modernatx.com/statements-perspectives/joint-statement-from-moderna-and-takeda-2021 0.8 monthly 2026-01-13 https://investors.modernatx.com/statements-perspectives/statement-on-myocarditis-and-pericarditis 0.8 monthly 2026-01-13 https://investors.modernatx.com/statements-perspectives/statement-on-intellectual-property 0.8 monthly 2026-01-13 https://investors.modernatx.com/statements-perspectives/joint-statement-from-moderna-and-takeda-on-the-investigation-of-suspended-lots-of-modernas-covid-19-vaccine-in-japan 0.8 monthly 2026-01-13 https://investors.modernatx.com/statements-perspectives/joint-statement-from-moderna-and-takeda 0.8 monthly 2026-01-13 https://investors.modernatx.com/statements-perspectives/covid-19-vaccination-requirement-for-all-workers-in-the-u-s 0.8 monthly 2026-01-13 https://investors.modernatx.com/statements-perspectives/statement-on-cvst-or-thrombotic-events 0.8 monthly 2026-01-13 https://investors.modernatx.com/statements-perspectives/statement-on-california-department-of-public-health-cdph-report 0.8 monthly 2026-01-13 https://investors.modernatx.com/statements-perspectives/statement-on-covid-19-vaccine-clinical-studies-in-children-adolescents 0.8 monthly 2026-01-13 https://investors.modernatx.com/statements-perspectives/modernas-updated-patent-pledge 0.8 monthly 2026-01-13 https://investors.modernatx.com/statements-perspectives/moderna-recall-notification-of-lot-000190a 0.8 monthly 2026-01-13 https://investors.modernatx.com/statements-perspectives/global-access-to-covid-19-vaccines 0.8 monthly 2026-01-13 https://investors.modernatx.com/statements-perspectives/statement-regarding-section-1498-motion-2022 0.8 monthly 2026-01-13 https://investors.modernatx.com/statements-perspectives/departure-of-jorge-gomez-and-continuation-of-david-meline-as-chief-financial-officer 0.8 monthly 2026-01-13 https://investors.modernatx.com/statements-perspectives/statement-regarding-section-1498-motion 0.8 monthly 2026-01-13 https://investors.modernatx.com/statements-perspectives/modernas-commitment-to-patient-access-in-the-united-states 0.8 monthly 2026-01-13 https://investors.modernatx.com/statements-perspectives/moderna-ramps-down-mrna-drug-substance-production-for-its-covid-19-vaccine-at-lonza 0.8 monthly 2026-01-13 https://investors.modernatx.com/statements-perspectives/modernas-efforts-to-ensure-significant-supply-of-covid-19-vaccines-reaches-pharmacies-and-points-of-care-in-the-us 0.8 monthly 2026-01-13 https://investors.modernatx.com/statements-perspectives/moderna-statement-on-anticipated-2023-covid-19-sales 0.8 monthly 2026-01-13 https://investors.modernatx.com/statements-perspectives/statement-on-kenya-manufacturing-facility 0.8 monthly 2026-01-13 https://investors.modernatx.com/statements-perspectives/statement-on-rsvvw-abstract-on-mrna-1345 0.8 monthly 2026-01-13 https://investors.modernatx.com/statements-perspectives/initiation-of-the-tender-procedure-for-mrna-covid-19-vaccines-by-the-health-emergency-preparedness-and-response-authority-hera-of-the-european-commission-ec 0.8 monthly 2026-01-13 https://investors.modernatx.com/statements-perspectives/moderna-licenses-covid-19-related-intellectual-property-to-a-pharmaceutical-company-in-japan 0.8 monthly 2026-01-13